Second Genome
  • About
    • About Us
    • Our Team
  • Pipeline
    • Pipeline
    • SG-5-00455
    • SG-3-06686
  • Platform
    • Platform
    • Drug Delivery System
    • Publications
    • Posters
  • News
    • News
    • Events
  • Careers
  • Contact

Poster

Strain-level meta-analysis of Parkinson’s disease-associated gut microbiome

October 24, 2021

READ MORE

Predicted Metabolites from Multiple Microbiome Sequencing Datasets Modulate Autism Spectrum Phenotype in Mice

October 23, 2021

READ MORE

Development and Validation of a Novel T Cell Modulating, Microbiome-Based Peptide for Combination with Immunotherapy

October 1, 2021

READ MORE

A Novel Microbiome‑Derived Peptide, SG‑3‑00802 Reverses Resistance to Anti‑Programmed Death Protein‑1 (PD‑1) Therapy

September 1, 2021

READ MORE

Metabolites Predicted from Multiple Microbiome Sequencing Datasets Modulate Autism Spectrum Phenotype in Mice

July 16, 2021

READ MORE

Novel Multi-Technology Microbiome Meta-Analysis in IBD Identifies Bacterial Peptides that Modulate IBD-Relevant T Cell Activity

July 1, 2021

READ MORE

Novel intestinal microbiome-derived peptides modulates immune cell activity and the tumor microenvironment

November 11, 2019

READ MORE

Leveraging the Second Genome platform to develop microbiome-derived cancer immunotherapies

October 30, 2019

READ MORE

Multi-Technology Meta-Analysis Identifies Bacterial Signatures Delineating Clinical Response to Immune Checkpoint-Inhibitor Therapy in Melanoma Cohorts

October 19, 2019

READ MORE

Novel intestinal microbiome-derived peptides modulates immune cell activity and the tumor microenvironment

September 17, 2019

READ MORE

Posts navigation

1 2 Next
Second Genome
  • About
  • Pipeline
  • Platform
  • News
  • Careers
  • Contact

Copyright © 2023 All rights reserved.